Home » Nymox Makes Progress in Global Marketing of Alzheimer Test
Nymox Makes Progress in Global Marketing of Alzheimer Test
Nymox Pharmaceutical continues to make progress in the global marketing strategy for the company's urine testing technology for Alzheimer's disease. The company now has attained U.S. federal and state CLIA approval in the U.S., and the CE Mark in Europe. The company recently announced a distribution and marketing agreement for Italy with Alifax.
ArriveNet (http://newark.dbusinessnews.com/shownews.php?newsid=16908&type_news=latest)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May